LAG3 and neoplasm: A role of dual blockade of LAG3 and PD-1 in tumor immunity is suggested by studies in which most tumors implanted in LAG3/PD-1 double-knockout mice were rejected, whereas PD-1 single-knockout mice showed delayed tumor growth.